ReAx is a Chicago-based, pre-clinical company that is applying next generation chemical proteomic platforms to discover, optimize and validate small molecules directly in cells. The ReAx pipeline enables interrogation of proteomic ‘dark matter’ – a landscape that is rarely studied, much less exploited for ligand discovery against high-value protein targets. By integrating our platforms with innovative chemistry, disease biology, and computational methods, we hope to deliver first-in-class therapeutics in oncology and immunological disease indications.
Company Details
- Employees
- 11
- Address
- 1375 W Fulton Market, Chicago,il 60607,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.reaxbio.com
- HQ
- Chicago, IL
Reax Biotechnologies Questions
Reax Biotechnologies's website is http://www.reaxbio.com
Reax Biotechnologies's LinkedIn profile is https://www.linkedin.com/company/reaxbio
Reax Biotechnologies has
11 employees.
View email and phone details for 11
employees at Reax Biotechnologies.
Reax Biotechnologies's industry is
Biotechnology Research
Reax Biotechnologies's top competitors are
Vanqua Bio,
Ctrl Therapeutics,
Kojin Therapeutics,
Anastasis Biotec,
Dimension Bio,
Nimbus Therapeutics,
Portal Innovations,
Circ Biosciences,
Grove Biopharma, Inc.,
Alnair Therapeutics.
Reax Biotechnologies's categories are Biotechnology Research
